Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis

Rheumatol Int. 2011 Mar;31(3):403-4. doi: 10.1007/s00296-009-1202-2. Epub 2009 Oct 15.

Authors

Athina Pyrpasopoulou¹, Stella Douma, Themistoklis Vassiliadis, Sofia Chatzimichailidou, Areti Triantafyllou, Spyros Aslanidis

Affiliation

¹ 2nd Propedeutic Department of Internal Medicine, Hippokration Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece. a.pyrpasopoulou@doctors.org.uk

PMID: 19830433
DOI: 10.1007/s00296-009-1202-2

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Murine-Derived / adverse effects*
Antibodies, Monoclonal, Murine-Derived / immunology
Antibodies, Monoclonal, Murine-Derived / therapeutic use
Arthritis, Rheumatoid / immunology
Arthritis, Rheumatoid / therapy*
Female
Hepatitis B, Chronic / immunology*
Hepatitis B, Chronic / virology
Humans
Immunologic Factors / adverse effects*
Immunologic Factors / immunology
Immunologic Factors / therapeutic use
Middle Aged
Recurrence
Rituximab

Substances

Antibodies, Monoclonal, Murine-Derived
Immunologic Factors
Rituximab